Lingvay I - Search Results

1

Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial.

Lingvay I, Catarig AM, Frias JP, Kumar H, Lausvig NL, le Roux CW, Thielke D, Viljoen A, McCrimmon RJ. Lingvay I, et al. Lancet Diabetes Endocrinol. 2019 Nov;7(11):834-844. doi: 10.1016/S2213-8587(19)30311-0. Epub 2019 Sep 17. Lancet Diabetes Endocrinol. 2019. PMID: 31540867 Clinical Trial.

2

Insulin as initial therapy in type 2 diabetes: effective, safe, and well accepted.

Lingvay I, Kaloyanova PF, Adams-Huet B, Salinas K, Raskin P. Lingvay I, et al. J Investig Med. 2007 Mar;55(2):62-8. doi: 10.2310/6650.2007.06036. J Investig Med. 2007. PMID: 17362692 Clinical Trial.

3

Effect of insulin-metformin combination on hepatic steatosis in patients with type 2 diabetes.

Lingvay I, Raskin P, Szczepaniak LS. Lingvay I, et al. J Diabetes Complications. 2007 May-Jun;21(3):137-42. doi: 10.1016/j.jdiacomp.2007.02.005. J Diabetes Complications. 2007. PMID: 17493545 Free PMC article. Clinical Trial.

4

Insulin-based versus triple oral therapy for newly diagnosed type 2 diabetes: which is better?

Lingvay I, Legendre JL, Kaloyanova PF, Zhang S, Adams-Huet B, Raskin P. Lingvay I, et al. Diabetes Care. 2009 Oct;32(10):1789-95. doi: 10.2337/dc09-0653. Epub 2009 Jul 10. Diabetes Care. 2009. PMID: 19592630 Free PMC article. Clinical Trial.

5

β-cell function preservation after 3.5 years of intensive diabetes therapy.

Harrison LB, Adams-Huet B, Raskin P, Lingvay I. Harrison LB, et al. Among authors: lingvay i. Diabetes Care. 2012 Jul;35(7):1406-12. doi: 10.2337/dc11-2170. Diabetes Care. 2012. PMID: 22723578 Free PMC article. Clinical Trial.

6

Type 1 diabetes treatment beyond insulin: role of GLP-1 analogs.

Harrison LB, Mora PF, Clark GO, Lingvay I. Harrison LB, et al. Among authors: lingvay i. J Investig Med. 2013 Jan;61(1):40-4. doi: 10.2310/JIM.0b013e318279b7d6. J Investig Med. 2013. PMID: 23222002

7

Intensive therapy in newly diagnosed type 2 diabetes: results of a 6-year randomized trial.

Harrison LB, Adams-Huet B, Li X, Raskin P, Lingvay I. Harrison LB, et al. Among authors: lingvay i. J Investig Med. 2014 Apr;62(4):676-86. doi: 10.2310/JIM.0000000000000068. J Investig Med. 2014. PMID: 24569485 Free PMC article. Clinical Trial.

8

Random blood glucose: a robust risk factor for type 2 diabetes.

Bowen ME, Xuan L, Lingvay I, Halm EA. Bowen ME, et al. Among authors: lingvay i. J Clin Endocrinol Metab. 2015 Apr;100(4):1503-10. doi: 10.1210/jc.2014-4116. Epub 2015 Feb 4. J Clin Endocrinol Metab. 2015. PMID: 25650899 Free PMC article.

9

Mechanisms of Action of Liraglutide in Patients With Type 2 Diabetes Treated With High-Dose Insulin.

Vanderheiden A, Harrison LB, Warshauer JT, Adams-Huet B, Li X, Yuan Q, Hulsey K, Dimitrov I, Yokoo T, Jaster AW, Pinho DF, Pedrosa I, Lenkinski RE, Pop LM, Lingvay I. Vanderheiden A, et al. Among authors: lingvay i. J Clin Endocrinol Metab. 2016 Apr;101(4):1798-806. doi: 10.1210/jc.2015-3906. Epub 2016 Feb 24. J Clin Endocrinol Metab. 2016. PMID: 26909799 Clinical Trial.

10

Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial.

Lingvay I, Pérez Manghi F, García-Hernández P, Norwood P, Lehmann L, Tarp-Johansen MJ, Buse JB; DUAL V Investigators. Lingvay I, et al. JAMA. 2016 Mar 1;315(9):898-907. doi: 10.1001/jama.2016.1252. JAMA. 2016. PMID: 26934259 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

230 results

Search Page

Filters